Atezolizumab and bevacizumab: the revolutionary duo as a game changer in advanced hepatocellular carcinoma

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	1
Number of pages	1
Journal	Immuno-Oncology and Technology
Volume	7
DOIs	https://doi.org/10.1016/j.iotech.2020.06.002
Publication status	Published - Sept 2020
Externally published	Yes

Access to Document

TY - JOUR

T1 - Atezolizumab and bevacizumab

T2 - the revolutionary duo as a game changer in advanced hepatocellular carcinoma

AU - Zhang, D. X.

PY - 2020/9

Y1 - 2020/9

UR - https://www.scopus.com/pages/publications/85096665225

U2 - 10.1016/j.iotech.2020.06.002

DO - 10.1016/j.iotech.2020.06.002

M3 - Letter

AN - SCOPUS:85096665225

VL - 7

SP - 1

JO - Immuno-Oncology and Technology

JF - Immuno-Oncology and Technology

ER -